Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 3Terminated 1Completed 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Leukemia 28Burkitt Lymphoma 6Recurrence 5Lymphoma 5Leukemia, Biphenotypic, Acute 3Lymphoma, T-Cell 2Lymphoma, Extranodal NK-T-Cell 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Mucositis 1Lymphoproliferative Disorders 1Leukemia, T-Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphoid 1Immunoproliferative Disorders 1Fallopian Tube Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Down Syndrome 1Dendritic Cell Sarcoma, Interdigitating 1Blast Crisis 1

Interventions

Vincristine 2Inotuzumab Ozogamicin 2Doxorubicin 2Dexamethasone 2Cyclophosphamide 2pegaspargase 1merphos 1dexamethasone acetate 1dexamethasone 21-phosphate 1azathiopurine 1auricularum 1Thioguanine 1Prednisone 1Methotrexate 1Mercaptopurine 1Leucovorin 1Lenalidomide 1Etoposide 1Cytarabine 1Calcium Dobesilate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × pegaspargase × Clear all
NCT01190930 2026-05-28

Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

Children's Oncology Group

Phase 3 Completed
9,350 enrolled 51 charts
LymphoidOther hematologic neoplasm

Down Syndrome, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡